Skip to main content
Equibles

Thrivent Financial for Lutherans

Position in RPRX — Royalty Pharma plc

CIK 314984 Minneapolis, MN
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$41,535,085
+$17,590,045 QoQ
Shares Held
740,772
+48.4% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#68
of 646 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $496,588,000 across 51 Biotechnology names. RPRX ranks #4 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TWST
Twist Bioscience Corp
 1,433,503 $147,478,787
2 EXEL
Exelixis, Inc.
 1,620,743 $88,184,625
3 REGN
Regeneron Pharmaceuticals, Inc.
 131,457 $81,968,697
4 RPRX
Royalty Pharma plc
This page 		740,772 $41,535,085
5 JAZZ
Jazz Pharmaceuticals plc
 80,500 $19,398,084
6 ARGX
Argenx SE
 12,688 $11,771,545
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,169 $10,018,546
8 VCEL
Vericel Corp
 170,272 $7,575,400

All Filings in RPRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,535,085 740,772
2026-03-31 $23,945,040 499,167
2025-12-31 $9,015,484 233,320
2025-09-30 $7,454,839 211,305
2025-06-30 $8,836,464 245,253
2025-03-31 $14,812,431 475,825
2024-12-31 $12,138,294 475,825
2024-09-30 $9,707,713 343,150
2024-06-30 $4,594,839 174,245
2024-03-31 $602,449 19,837
2023-12-31 $557,220 19,837
2023-09-30 $585,598 21,577
2023-06-30 $744,430 24,217